WealthShare

We are incredibly proud to share that Natasha Phipps has been nominated for Female Trailblazer of the Year at the 2026 Wealth Professional Awards.

Now in its twelfth year, the Wealth Professional Awards recognize the advisors, firms, and leaders helping shape the future of Canada’s wealth management industry. The awards ceremony will take place June 4 in Toronto, bringing together some of the industry’s most respected voices for an evening celebrating leadership, innovation, and impact.

This nomination reflects Natasha’s continued commitment to building something meaningful through education, real estate investment, and creating opportunities for Canadians to participate in long-term wealth building through hard assets.

Natasha, your leadership, vision, and dedication continue to leave a lasting impact, and this recognition is so well deserved.

Markets change. Strategies evolve.
But informed investors keep moving!

At WealthShare, we spend a lot of time focused on what’s actually happening in the market, beyond headlines and noise.

Because building wealth isn’t about reacting emotionally. It’s about understanding opportunity when it’s in front of you.

If you’ve been thinking about passive real estate investing, now is the time to start asking questions. We’re here! ✨

Multifamily investing looks different in 2026.

And CMHC MLI Select is still a major part of the conversation, but how it’s actually being used is shifting.
In this webinar, we’re breaking it down in real terms:
What’s working. What’s not. And what it really takes to get deals across the finish line right now.

We’ll cover:
• Where opportunity is still showing up
• The risks investors are underestimating
• How rates, costs, and underwriting are impacting deals
• What “CMHC approval” actually means in ex*****on.

This isn’t theory. It’s how deals are being structured today.

📅 May 6 | 6–7 PM MDT
💻 Online

If you’re involved in multifamily, development, or financing, this is a conversation worth being in.

Register through the link in bio.